Cited by 367Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismCardiovascular Disease and Adiposity

Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity

Open access
Muir, Lindsey A., Neeley, Christopher K., Meyer, Kevin A., Baker, Nicki A., Brosius, Alice M., Washabaugh, Alexandra R., Varban, Oliver A., Finks, Jonathan F. +9 more·2016·Obesity

Abstract

OBJECTIVE: The relationship between adipose tissue fibrosis, adipocyte hypertrophy, and preadipocyte hyperplasia in the context of obesity and the correlation of these tissue-based phenomena with systemic metabolic disease are poorly defined. The goal of this study was to clarify the relationship between adipose tissue fibrosis, adipocyte hypertrophy, and preadipocyte hyperplasia in human obesity and determine the correlation of these adipose-tissue based phenomena with diabetes. METHODS: Visceral and subcutaneous adipose tissues from humans with obesity collected during bariatric surgery were studied with QRTPCR, immunohistochemistry, and flow cytometry for expression of collagens and fibrosis-related proteins, adipocyte size, and preadipocyte frequency. Results were correlated with clinical characteristics including diabetes status. RESULTS: Fibrosis was decreased, hypertrophy was increased, and preadipocyte frequency and fibrotic gene expression were decreased in adipose tissues from diabetic subjects compared to non-diabetic subjects. These differences were greater in visceral compared to subcutaneous adipose tissue. CONCLUSIONS: These data are consistent with the hypothesis that adipose tissue fibrosis in the context of human obesity limits adipocyte hypertrophy and is associated with a reciprocal increase in adipocyte hyperplasia, with beneficial effects on systemic metabolism. These findings suggest adipose tissue fibrosis as a potential target for manipulation of adipocyte metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.21377

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Muir, L. A., Neeley, C. K., Meyer, K. A., Baker, N. A., Brosius, A. M., Washabaugh, A. R., Varban, O. A., Finks, J. F., Zamarron, B. F., Flesher, C. G., Chang, J. S., DelProposto, J. B., Geletka, L., Martinez‐Santibanez, G., Kaciroti, N., Lumeng, C. N., & O'Rourke, R. W.
Affiliations
  • University of Michigan (US)
  • Department of Pediatrics and Communicable Diseases University of Michigan Medical School Ann Arbor Michigan USA
  • Department of Surgery University of Michigan Medical School Ann Arbor Michigan USA
Venue
Obesity
Publisher
Wiley
Published
2016-02-25
Volume
24
Issue
3
Pages
597-605
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W2284433125
Cited by
367
References
37
Citations by year
2026: 20 · 2025: 29 · 2024: 47 · 2023: 46 · 2022: 52 · 2021: 53 · 2020: 33 · 2019: 23 · 2018: 36 · 2017: 21 · 2016: 7
FWCI
27.20
Type
journal article
Language
en
Open access
Locations
  • Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
  • National Institutes of Health (UL1TR000433)
  • National Institute of General Medical Sciences (T32GM007315)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, R01DK090262, DK090262, R01DK097449, T32DK094775, T32DK101357)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
adipose tissue fibrosis, adipocyte hypertrophy, type 2 diabetes, visceral adipose tissue, subcutaneous adipose tissue, collagen expression, adipocyte size, bariatric surgery
MeSH terms
Adipose Tissue, Diabetes Mellitus, Type 2, Female, Fibrosis, Humans, Hyperplasia, Hypertrophy, Male, Middle Aged, Obesity, Adipocytes, Bariatric Surgery, Subcutaneous Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review